These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 9578419)

  • 1. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.
    Hicklin DJ; Dellaratta DV; Kishore R; Liang B; Kageshita T; Ferrone S
    Melanoma Res; 1997 Aug; 7 Suppl 2():S67-74. PubMed ID: 9578419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
    Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
    del Campo AB; Aptsiauri N; Méndez R; Zinchenko S; Vales A; Paschen A; Ward S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F
    Scand J Immunol; 2009 Aug; 70(2):125-35. PubMed ID: 19630918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.
    Martayan A; Fraioli R; Giorda E; Setini A; Ciccarelli G; Delfino L; Ferrara GB; Giacomini P
    Br J Cancer; 1999 May; 80(5-6):639-49. PubMed ID: 10360639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
    Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
    J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
    Wang Z; Arienti F; Parmiani G; Ferrone S
    Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
    Hicklin DJ; Wang Z; Arienti F; Rivoltini L; Parmiani G; Ferrone S
    J Clin Invest; 1998 Jun; 101(12):2720-9. PubMed ID: 9637706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of melanoma tumor antigen activity with beta2-microglobulin.
    Malley A; Burger DR; Vandenbark AA; Frikke M; Finke P; Begley D; Acott K; Black J; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):619-23. PubMed ID: 83915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
    Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
    Ohnmacht GA; Marincola FM
    J Cell Physiol; 2000 Mar; 182(3):332-8. PubMed ID: 10653599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.
    Wang Z; Seliger B; Mike N; Momburg F; Knuth A; Ferrone S
    Cancer Res; 1998 May; 58(10):2149-57. PubMed ID: 9605759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA expression in choroidal melanomas: correlation with clinicopathological features.
    Krishnakumar S; Abhyankar D; Lakshmi SA; Pushparaj V; Shanmugam MP; Biswas J
    Curr Eye Res; 2004 Jun; 28(6):409-16. PubMed ID: 15512948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of human leukocyte antigen class I and II and beta 2-microglobulin expression in human herpesvirus-7-infected cells.
    Mirandola P; Sponzilli I; Solenghi E; Micheloni C; Rinaldi L; Gobbi G; Vitale M
    J Infect Dis; 2006 Apr; 193(7):917-26. PubMed ID: 16518752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.